We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

54 hedge funds and large institutions have $120M invested in Intersect ENT, Inc in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

20% more capital invested

Capital invested by funds: $100M → $120M (+$20.3M)

8% more funds holding

Funds holding: 5054 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
54
Holders Change
+4
Holders Change %
+8%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
12
Increased
21
Reduced
13
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
51
UBS Group
Switzerland
$24K +$23.5K +1,308 New
TDC
52
Thompson Davis & Co
Virginia
$5K +$2.25K +125 +100%
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$1K +$1.04K +58 New
Manulife (Manufacturers Life Insurance)
54
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$29 +$28.1K +1,560 New
Alyeska Investment Group
55
Alyeska Investment Group
Illinois
-$3.21M -207,123 Closed
Adage Capital Partners
56
Adage Capital Partners
Massachusetts
-$2.33M -150,000 Closed
CSS
57
Cubist Systematic Strategies
Connecticut
-$200K -12,881 Closed
SIM
58
Spark Investment Management
New York
-$180K -11,600 Closed
Citadel Advisors
59
Citadel Advisors
Florida
-$169K -10,894 Closed
SO
60
STRS Ohio
Ohio
-$31K -2,000 Closed
TRCT
61
Tower Research Capital (TRC)
New York
-$15K -959 Closed

XENT Hedge Fund Activity: Q4 2014 in Review

54 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2014, worth a combined $120M — up 20% from $100M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new XENT positions and 7 closed out — a net gain of 5 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was Wells Fargo, adding an estimated $3.41M. The largest seller was Wellington Management Group, cutting an estimated $4.65M.

  • 54 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2014, up from 50 in Q3 2014.
  • Funds reported $120M of Intersect ENT, Inc stock for Q4 2014, up 20% quarter-over-quarter.
  • 12 funds opened new Intersect ENT, Inc positions in Q4 2014 and 7 closed out, a net change of +5 holders.
  • The largest Intersect ENT, Inc buyer in Q4 2014 was Wells Fargo, an estimated $3.41M added.
  • The largest Intersect ENT, Inc seller in Q4 2014 was Wellington Management Group, an estimated $4.65M sold.

Based on aggregated 13F filings for Q4 2014.